Medgenics Receives Orphan Drug Designation From FDA for

Medgenics Receives Orphan Drug Designation from FDA for

Filed under: drug treatment news stories

This marks the first Orphan Drug Designation granted for treatment of a clinical indication using the Biopump. Orphan …. Recent Stories from Medgenics, Inc.
Read more on EON: Enhanced Online News (press release)

 

Orexo Advances on Addiction Drug Study Result: Stockholm Mover

Filed under: drug treatment news stories

A dosage test on OX219, a treatment for opioid addiction, was finished … the reporter on this story: Janina Pfalzer in Stockholm at [email protected].
Read more on Bloomberg

 

Ryan Leaf sentenced to treatment for drugs

Filed under: drug treatment news stories

Former NFL quarterback Ryan Leaf could spend 15 months locked down in Montana, first in a secure drug treatment facility and then in a pre-release living …
Read more on WALA-TV FOX10

 

Images of Medgenics Receives Orphan <b>Drug</b> Designation from FDA for <b>…</b>” title=”Images of Medgenics Receives Orphan <b>Drug</b> Designation from FDA for <b>…</b>” /></a> </p>
<p style=Medgenics Receives Orphan Drug Designation From FDA For INFRADURE Biopump To Treat Hepatitis D
Medgenics, Inc. , the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that its INFRADURE™ Biopump has received Orphan Drug Designation from the U.S. … Read News

Medgenics Receives Orphan <b>Drug</b> Designation from FDA for <b>…</b> Pictures” title=”Medgenics Receives Orphan <b>Drug</b> Designation from FDA for <b>…</b> Pictures” /></a> </p>
<p style=Medgenics Receives Orphan Drug Designation From FDA For INFRADURE Biopump To Treat Hepatitis D
MISGAV, Israel & SAN FRANCISCO–(BUSINESS WIRE)–Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that its INFRADURE™ Biopump has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan … Read News